Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01387945 · ClinicalTrials.gov registry record · NA

Pilot Study of Home Blood Pressure Control Program (eBP Control)

A NA study, sponsored by Memorial Hospital of Rhode Island.

Completed
Registry status
NA
Development phase
28
Enrollment target

NCT01387945: Completed NA study, sponsored by Memorial Hospital of Rhode Island.

NCT01387945 is a NA study that has completed, run by Memorial Hospital of Rhode Island. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01387945, a NA study, has completed, sponsored by Memorial Hospital of Rhode Island.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target

Study Summary

This intervention study will evaluate the feasibility,acceptability and effectiveness of an e-health enabled model of care by randomly assigning a trained patient navigator and/or a blood pressure (BP) self-management web portal to patients with uncontrolled hypertension after a run in period with a home BP monitor (HBPM) and comparing the results on blood pressure control. We anticipate that patients receiving the combination of a patient navigator(PN)with a self-management web portal and home BP monitor will have better BP control than when the only received a home BP monitor.

Primary Outcome

Percentage of patients at systolic and/or diastolic blood pressure at goal at the fourth research visit (end of the study)

Interventions

  • BEHAVIORAL HBPM+website+patient navigator

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2010-09
Est. Completion 2012-09
Phase NA

What the finished NCT01387945 record still lists

NCT01387945 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which HBPM+website+patient navigator is the first listed.

NCT01387945 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01387945 about?

NCT01387945 is a clinical study titled "Pilot Study of Home Blood Pressure Control Program (eBP Control)". This intervention study will evaluate the feasibility,acceptability and effectiveness of an e-health enabled model of care by randomly assigning a trained patient navigator and/or a blood pressure (BP) self-management web portal to patients with uncontrolled hypertension after a run in period with a...

What is the current status of trial NCT01387945?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2010-09. Estimated completion is 2012-09.

What interventions are being tested in trial NCT01387945?

The interventions under investigation include: HBPM+website+patient navigator (BEHAVIORAL).

Who is sponsoring clinical trial NCT01387945?

This trial is sponsored by Memorial Hospital of Rhode Island, which has 5 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01387945's enrollment target sits among peer trials

28 1704th of 2000 higher than 293 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03471117 · 28 participants · Phase 4

    Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

  • NCT03523975 · 28 participants · Phase 1

    Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

  • NCT03608631 · 28 participants · Phase 1

    iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

  • NCT03810651 · 28 participants · Early Phase 1

    Pencil Beam Scanning in Patients With Renal Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01387945, the US trial registry maintained by the National Library of Medicine. NCT01387945 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.